Canada markets closed

Eureka 93 Inc. (LXLLF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.00010.0000 (0.00%)
At close: 9:32AM EDT

Eureka 93 Inc.

179 Promenade du Portage
3rd Floor Suite 300
Gatineau, QC J8X 2K5
Canada
819-718-2042
http://www.eureka93.com

Sector(s)
Industry
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Seann PoliCo-CEO & Director202.81kN/A1968
Mr. Peter OstapchukChief Financial Officer4.11kN/AN/A
Owen KenneyCo-CEO & DirectorN/AN/AN/A
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Eureka 93 Inc., a cannabidiol (CBD) life sciences company, engages in the research, development, extraction, production, processing, and distribution of CBD and other cannabinoids in the United States and Canada. The company offers hemp-derived CBD products, full plant extracts, and isolate powder. It is also involved in the development and manufacture of natural health products, as well as nutraceutical contract manufacturing business. The company is headquartered in Gatineau, Canada.

Corporate Governance

Eureka 93 Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.